Stratasys Expands Availability of RadioMatrix Radiopaque Material in the US.

Stratasys has expanded the availability of its RadioMatrix radiopaque material in the US, allowing healthcare providers, device manufacturers, and research institutions to access and utilize the material for advanced medical imaging and training applications. The material enables precise control of radiopacity and can produce patient-specific models with repeatable, consistent, and fully tunable visibility on X-ray-based imaging. It has been validated by Siemens Healthineers and is expected to improve how radiologists validate and optimize CT protocols and accelerate the development of new imaging algorithms.